For help on how to get the results you want, see our search tips.
2 results
Medicine
Referrals Remove Referrals filter
Referral type
Article 20 procedures Remove Article 20 procedures filter
Article 31 referrals Remove Article 31 referrals filter
Article 29(4) referrals Remove Article 29(4) referrals filter
Referral safety status
Yes Remove Yes filter
Referral authorisation model
Centrally authorised product(s) Remove Centrally authorised product(s) filter
Medicine type
Conditional approval Remove Conditional approval filter
Additional monitoring Remove Additional monitoring filter
Referral PRAC recommendation
Risk minimisation measures Remove Risk minimisation measures filter
-
List item
Referral: Xeljanz
tofacitinib, associated names: Xeljanz, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 31/01/2020, Last updated: 06/03/2020 -
List item
Referral: Lemtrada
alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020